We also observed the enrichment of several immunological signatures, such as “TNFα/NFκB signaling” and “immune cells”, which was consistent with the immune infiltration findings, suggesting that KRAS may affect the anti-tumor immune response (Figure 10A,D and Figure 11). The gene discussed is NFKB1; the disease is neoplasm.